List of Tables
Table 1. Global Varicella Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Varicella Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Varicella Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Varicella Vaccine Sales (M Doses) of Key Manufacturers (2019-2024)
Table 5. Global Varicella Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Varicella Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Varicella Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Varicella Vaccine Average Price (USD/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Varicella Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Varicella Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Varicella Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Varicella Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Varicella Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Varicella Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Varicella Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Varicella Vaccine Sales by Region (2019-2024) & (M Doses)
Table 18. Global Varicella Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Varicella Vaccine Sales by Region (2025-2030) & (M Doses)
Table 20. Global Varicella Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Varicella Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Varicella Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Varicella Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Varicella Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Varicella Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Varicella Vaccine Sales by Country (2019-2024) & (M Doses)
Table 27. North America Varicella Vaccine Sales by Country (2025-2030) & (M Doses)
Table 28. North America Varicella Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Varicella Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Varicella Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Varicella Vaccine Sales by Country (2019-2024) & (M Doses)
Table 32. Europe Varicella Vaccine Sales by Country (2025-2030) & (M Doses)
Table 33. Europe Varicella Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Varicella Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Varicella Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Varicella Vaccine Sales by Region (2019-2024) & (M Doses)
Table 37. Asia Pacific Varicella Vaccine Sales by Region (2025-2030) & (M Doses)
Table 38. Asia Pacific Varicella Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Varicella Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Varicella Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Varicella Vaccine Sales by Country (2019-2024) & (M Doses)
Table 42. Latin America Varicella Vaccine Sales by Country (2025-2030) & (M Doses)
Table 43. Latin America Varicella Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Varicella Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Varicella Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Varicella Vaccine Sales by Country (2019-2024) & (M Doses)
Table 47. Middle East & Africa Varicella Vaccine Sales by Country (2025-2030) & (M Doses)
Table 48. Middle East & Africa Varicella Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Varicella Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Varicella Vaccine Sales (M Doses) by Type (2019-2024)
Table 51. Global Varicella Vaccine Sales (M Doses) by Type (2025-2030)
Table 52. Global Varicella Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Varicella Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Varicella Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Varicella Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Varicella Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Varicella Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Varicella Vaccine Price (USD/Dose) by Type (2019-2024)
Table 59. Global Varicella Vaccine Price (USD/Dose) by Type (2025-2030)
Table 60. Global Varicella Vaccine Sales (M Doses) by Application (2019-2024)
Table 61. Global Varicella Vaccine Sales (M Doses) by Application (2025-2030)
Table 62. Global Varicella Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Varicella Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Varicella Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Varicella Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Varicella Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Varicella Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Varicella Vaccine Price (USD/Dose) by Application (2019-2024)
Table 69. Global Varicella Vaccine Price (USD/Dose) by Application (2025-2030)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 73. Merck Varicella Vaccine Product
Table 74. Merck Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 78. GSK Varicella Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. Shanghai Institute Corporation Information
Table 81. Shanghai Institute Description and Business Overview
Table 82. Shanghai Institute Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 83. Shanghai Institute Varicella Vaccine Product
Table 84. Shanghai Institute Recent Developments/Updates
Table 85. BCHT Corporation Information
Table 86. BCHT Description and Business Overview
Table 87. BCHT Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 88. BCHT Varicella Vaccine Product
Table 89. BCHT Recent Developments/Updates
Table 90. Changsheng Corporation Information
Table 91. Changsheng Description and Business Overview
Table 92. Changsheng Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 93. Changsheng Varicella Vaccine Product
Table 94. Changsheng Recent Developments/Updates
Table 95. Keygen Corporation Information
Table 96. Keygen Description and Business Overview
Table 97. Keygen Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 98. Keygen Varicella Vaccine Product
Table 99. Keygen Recent Developments/Updates
Table 100. Green Cross Corporation Information
Table 101. Green Cross Description and Business Overview
Table 102. Green Cross Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 103. Green Cross Varicella Vaccine Product
Table 104. Green Cross Recent Developments/Updates
Table 105. Biken Corporation Information
Table 106. Biken Description and Business Overview
Table 107. Biken Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 108. Biken Varicella Vaccine Product
Table 109. Biken Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Varicella Vaccine Distributors List
Table 113. Varicella Vaccine Customers List
Table 114. Varicella Vaccine Market Trends
Table 115. Varicella Vaccine Market Drivers
Table 116. Varicella Vaccine Market Challenges
Table 117. Varicella Vaccine Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Varicella Vaccine
Figure 2. Global Varicella Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Varicella Vaccine Market Share by Type in 2023 & 2030
Figure 4. Injection Product Picture
Figure 5. Freeze-Dried Powder Product Picture
Figure 6. Global Varicella Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Varicella Vaccine Market Share by Application in 2023 & 2030
Figure 8. Kids Injection
Figure 9. Adults Injection
Figure 10. Global Varicella Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Varicella Vaccine Market Size (2019-2030) & (US$ Million)
Figure 12. Global Varicella Vaccine Sales (2019-2030) & (M Doses)
Figure 13. Global Varicella Vaccine Average Price (USD/Dose) & (2019-2030)
Figure 14. Varicella Vaccine Report Years Considered
Figure 15. Varicella Vaccine Sales Share by Manufacturers in 2023
Figure 16. Global Varicella Vaccine Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Varicella Vaccine Players: Market Share by Revenue in 2023
Figure 18. Varicella Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Varicella Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Varicella Vaccine Sales Market Share by Country (2019-2030)
Figure 21. North America Varicella Vaccine Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Varicella Vaccine Sales Market Share by Country (2019-2030)
Figure 25. Europe Varicella Vaccine Revenue Market Share by Country (2019-2030)
Figure 26. Germany Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Varicella Vaccine Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Varicella Vaccine Revenue Market Share by Region (2019-2030)
Figure 33. China Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Varicella Vaccine Sales Market Share by Country (2019-2030)
Figure 43. Latin America Varicella Vaccine Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Varicella Vaccine Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Varicella Vaccine Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Varicella Vaccine by Type (2019-2030)
Figure 53. Global Revenue Market Share of Varicella Vaccine by Type (2019-2030)
Figure 54. Global Varicella Vaccine Price (USD/Dose) by Type (2019-2030)
Figure 55. Global Sales Market Share of Varicella Vaccine by Application (2019-2030)
Figure 56. Global Revenue Market Share of Varicella Vaccine by Application (2019-2030)
Figure 57. Global Varicella Vaccine Price (USD/Dose) by Application (2019-2030)
Figure 58. Varicella Vaccine Value Chain
Figure 59. Varicella Vaccine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed